What should be monitored while a patient is on Valproic Acid?

While a patient is on Valproic Acid, it is crucial to monitor liver function tests. Valproic Acid is known for its potential hepatotoxicity, which can lead to liver damage, especially in the first six months of treatment. Regular monitoring of liver function tests helps detect any early signs of liver injury, allowing for timely intervention and management.

Although a Complete Blood Count (CBC) is important in assessing the overall health of a patient and monitoring for blood dyscrasias, it is the liver function tests that are particularly significant when considering the risks associated with Valproic Acid. Other tests, such as blood glucose levels and electrolyte levels, are not specifically required for monitoring in patients taking this medication.